Maze Therapeutics, Inc. (MAZE)

NGM – Real Time Price. Currency in USD

25.78

+0.26 (1.02%)

At close: May 12, 2026, 4:00 PM EDT

26.62

+0.84 (3.26%)

After-hours: May 12, 2026, 7:41 PM EDT

Ownership

Breakdown
1.48%	% of Shares Held by All Insider
95.36%	% of Shares Held by Institutions
96.79%	% of Float Held by Institutions
188	Number of Institutions Holding Shares

Holder	Shares	Date Reported	% Out	Value
TRV GP IV, LLC	4.47M	2026-03-31	8.99%	$116.46M

Holder	Shares	Date Reported	% Out	Value
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.15M	2025-12-31	2.32%	$30.00M
iShares Trust-iShares Russell 2000 ETF	639,112	2026-03-31	1.28%	$16.64M
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund	324,041	2025-12-31	0.65%	$8.43M
Fidelity Select Portfolios-Select Biotechnology Portfolio	311,885	2026-03-31	0.63%	$8.12M
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	229,638	2025-12-31	0.46%	$5.98M
iShares Trust-iShares Russell 2000 Value ETF	211,159	2026-03-31	0.42%	$5.50M
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	209,909	2026-02-28	0.42%	$5.46M
iShares Trust-iShares Biotechnology ETF	198,348	2026-03-31	0.40%	$5.16M
BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio	184,453	2026-02-28	0.37%	$4.80M
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund	128,000	2026-02-28	0.26%	$3.45M
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF	117,041	2026-03-31	0.24%	$3.05M
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund	110,869	2026-01-31	0.23%	$5.59M